Virtu KCG Holdings’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$593K Buy
+24,633
New +$540K 0.02% 987
2017
Q1
Sell
-78,571
Closed -$1.89M 3590
2016
Q4
$1.89M Buy
+78,571
New +$2.19M 0.05% 343
2016
Q3
Sell
-48,380
Closed -$1.18M 3362
2016
Q2
$1.18M Buy
48,380
+40,166
+489% +$1.14M 0.02% 633
2016
Q1
$276K Sell
8,214
-18,291
-69% -$576K 0.01% 1787
2015
Q4
$792K Buy
26,505
+16,470
+164% +$555K 0.01% 1060
2015
Q3
$316K Sell
10,035
-7,265
-42% -$354K 0.01% 2030
2015
Q2
$837K Buy
+17,300
New +$729K 0.02% 1015
2014
Q3
Sell
-62,848
Closed -$1.51M 3939
2014
Q2
$1.51M Buy
+62,848
New +$1.27M 0.02% 765

Other funds holding PGEN

Virtu KCG Holdings's PGEN Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Precigen (PGEN) in Q2 2017: 24,633 shares worth $593K. The stake represents 0.02% of the portfolio and ranks #987 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in PGEN as recently as Q4 2016.

Virtu KCG Holdings first reported a position in PGEN in Q2 2014 and has held it in 8 quarters since. The position peaked at $1.89M in Q4 2016. 172 funds tracked by Wall St. Rank hold PGEN as of Q2 2017.

  • Virtu KCG Holdings held 24,633 shares of Precigen worth $593K as of Q2 2017.
  • Precigen was a new Virtu KCG Holdings position in Q2 2017.
  • Precigen made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #987 holding.
  • Virtu KCG Holdings first reported a position in Precigen in Q2 2014 and has held it in 8 quarters since.
  • Virtu KCG Holdings's Precigen position peaked at $1.89M in Q4 2016.
  • 172 funds tracked by Wall St. Rank held Precigen as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.